Involvement of Dopamine in Development of Hypertension in Spontaneously Hypertensive Rat: Effect of Carbidopa, Inhibitor of Peripheral DOPA Decarboxylase

References

• Kondo K., Ebihara A., Suzuki H., Saruta T. Role of dopamine in the regulation of blood pressure and the renin-angiotensin-aldosterone system in conscious rats. Clin Sci. 1981; 61: 235s–237s
   PubMed Web of Science ®Google Scholar
• Taylor A. A., Fennell W. H., Feldman M. B., Brandon B. S., Ginos J. Z., Mitchell J. R. Activation of peripheral dopamine presynaptic receptors lowers blood pressure and heart rate in dogs. Hypertension. 1983; 5: 226–234
   PubMed Web of Science ®Google Scholar
• Kambara S., Yoshimura M., Okabayashi H., Takahashi H., Ijichi H. Attenuated development of hypertension by chronic administration of bromocriptine in DOCA-salt hypertensive rats. Jpn Circ J. 1986; 50: 1120–1127
   PubMedGoogle Scholar
• Johns D. W., Ayers C. R., Carey R. M. The dopamine agonist bromocriptine induces hypotension by venous and arteriolar dilation. J Cardiovasc Pharmacol. 1984; 6: 582–587
   PubMed Web of Science ®Google Scholar
• Sowers J. R., Golub M. S., Berger M. E., Whitfield L. A. Dopaminergic modulation of pressor and hormonal responses in essential hypertension. Hypertension. 1982; 4: 424–430
   PubMed Web of Science ®Google Scholar
• Sowers J. R., Nyby M., Jasberg K. Dopaminergic control of prolactin and blood pressure: altered control in essential hypertension. Hypertension. 1982; 4: 431–438
   PubMed Web of Science ®Google Scholar
• van den Buuse M., Versteeg D. H.G., de Jong W. Role of dopamine in the development of spontaneous hypertension. Hypertension. 1984; 6: 899–905
   PubMed Web of Science ®Google Scholar
• Morris M., Sundberg D. K. Neurohypophyseal dopamine biosynthesis in spontaneously hypertensive rat. Clin Exper Hypertension. 1981; 3: 1165–1181
   PubMed Web of Science ®Google Scholar
• Willems J. L., Bogaert M. G., Buylaert W. Preliminary observations on the interaction of domperidone with peripheral dopamine receptors. Japan J Pharmacol. 1981; 31: 131–133
   PubMedGoogle Scholar
• Porter C. C. Aromatic amino acid decarboxylase inhibitors. Fed Proc. 1971; 30: 871–876
   PubMedGoogle Scholar
• Riggin R. M., Kissinger P. T. Determination of catecholamines in urine by reverse-phase liquid chromatography with electrochemical detection. Anal Chem. 1977; 49: 2109–2111
   PubMed Web of Science ®Google Scholar
• Felice L. J., Felice J. D., Kissinger J. Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography. J Neurochem. 1978; 31: 1461–1465
   PubMed Web of Science ®Google Scholar
• Snedecor G. W., Cochran W. G. Statistical methods, Sixth edition. Iowa state University Press, Ames, Iowa 1967
   Google Scholar
• Kjeldsen S. E., Flaaten B., Eide I., Helgeland A., Leren P., Fontelien E. Decreased peripheral dopaminergic activity in essential hypertension?. Scand J Clin Lab Invest. 1983; 43: 15–20
   PubMed Web of Science ®Google Scholar
• Lackovic Z., Relja M. Evidence for a widely distributed peripheral dopaminergic system. Fed Proc. 1983; 42: 3000–3004
   PubMedGoogle Scholar
• Ball S. G., Lee M. R. The effect of carbidopa administration on urinary sodium excretion in man. Is dopamine an intrarenal natriuretic hormone?. Br J Clin Pharmac. 1977; 4: 115–119
   PubMed Web of Science ®Google Scholar
• Brodde O. E. Demonstration of vascular dopamine receptors in membranes from rabbit renal artery using 3H-spiroperidol binding. Experientia 1980; 37: 1099–1101
   Google Scholar
• Lokhandwala W. F., Jandhyala B. S. The role of the nervous system in the vascular actions of dopamine. J Pharmacol Exp Ther. 1979; 210: 120–126
   PubMed Web of Science ®Google Scholar
• Schmidt M., Schmidt J. L., Schwartz J. The vascular dopamine receptor: a review. J Pharmacol. 1981; 12: 355–382
   PubMedGoogle Scholar
• Felder R. A., Blecher M., Eisner G. M., Jose P. A. Cortical tubular and glomerular dopamine receptors in the kidney. Am J Physiol. 1984; 246: F557–F568
   PubMed Web of Science ®Google Scholar
• Yoshimura M., Kambara S., Okabayashi H., Takahashi H., Ijichi H. Effect of decreased dopamine synthesis on the development of hypertension induced by salt loading in spontaneously hypertensive rats. Clin Exp Hypertension
   Web of Science ®Google Scholar
• Yamazaki H., Yoshimura M., Takashina R., Kambara S., Lee L. C., Sasaki S., Takahashi H., Ijichi H. Enhanced renal sympathetic activity in response to salt loading in rats. Jpn Circ J. 1986; 50: 442–448
   PubMedGoogle Scholar
• Winternitz S. R., Oparil S. Sodium-neural interactions in the development of spontaneous hypertension. Clin Exp Hypertension. 1982; 4: 751–760
   Web of Science ®Google Scholar
• Goldberg L. I. Dopamine receptors and hypertension. physiologic and pharmacologic implications. Am J Med. 1984; 77: 37–44
   PubMed Web of Science ®Google Scholar
• Udenfriend S., Zaltzman-Nirenberg N., Gordon R., Spector S. Evaluation of the biochemical effects produced in vivo by inhibitors of the three enzymes involved in norepinephrine biosynthesis. Mol Pharmacol. 1966; 2: 95–105
   PubMed Web of Science ®Google Scholar
• Alonso R., Agharanya J. C., Wurtman R. J. Tyrosine loading enhances catecholamine excretion by rats. J Neural Transmission. 1980; 49: 31–43
   PubMed Web of Science ®Google Scholar
• Udenfriend S., Zaltzman-Nirenberg P. On the mechanism of the norepinephrine release produced by α-methyl-meta-tyrosine. J Pharmacol Exp Ther. 1962; 138: 194–199
   PubMed Web of Science ®Google Scholar